Synergy of advanced machine learning and deep neural networks with consensus molecular dock- ing for enhanced potency prediction of ALK inhibitors,
Published in Scientific Reports , 2023
This study addresses the urgent need for new Anaplastic lymphoma kinase (ALK) inhibitors in Non-Small Cell Lung Cancer (NSCLC), focusing on the ALK-positive mutation variant (5% of cases)…
Download here